A new study published in the Journal ofNeurology Neurosurgery and Psychiatry finds that Prozac, acommonly prescribed antidepressant, may be an agent in slowingdown the disease process of the relapsing remitting form of multiplesclerosis (MS).Multiple sclerosis is an autoimmune disease where the immune systemattacks the central nervous system. In the relapsing remitting form,new symptoms occur in discrete attacks.
Popularity: unranked [?]
Related posts:
- Increasing Positive Experiences Decreases Depression Symptoms In Patients With Multiple Sclerosis
- A Beautiful New Model For MS
- New Insights Into Autoimmunity And Depression
- Postpartum Depression More Prevalent In Mothers Of Multiple Births
- Rexahn Achieves 50% Enrollment Milestone In Serdaxin™ Phase IIa Clinical Trial For Depression
Comments
No Responses to “Multiple Sclerosis Activity May Be Affected By Prozac”